163 related articles for article (PubMed ID: 29677603)
1. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews.
Monden R; Roest AM; van Ravenzwaaij D; Wagenmakers EJ; Morey R; Wardenaar KJ; de Jonge P
J Affect Disord; 2018 Aug; 235():393-398. PubMed ID: 29677603
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
6. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
Gaillard R
Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
[TBL] [Abstract][Full Text] [Related]
7. Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study.
Luo Y; Chaimani A; Kataoka Y; Ostinelli EG; Ogawa Y; Cipriani A; Salanti G; Furukawa TA
BMJ Open; 2018 Dec; 8(12):e023222. PubMed ID: 30530583
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
Shinohara K; Efthimiou O; Ostinelli EG; Tomlinson A; Geddes JR; Nierenberg AA; Ruhe HG; Furukawa TA; Cipriani A
BMJ Open; 2019 May; 9(5):e027574. PubMed ID: 31110100
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
10. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.
Tomlinson A; Efthimiou O; Boaden K; New E; Mather S; Salanti G; Imai H; Ogawa Y; Tajika A; Kishimoto S; Kikuchi S; Chevance A; Furukawa TA; Cipriani A
Evid Based Ment Health; 2019 May; 22(2):61-66. PubMed ID: 30996028
[TBL] [Abstract][Full Text] [Related]
11. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses.
Juul S; Siddiqui F; Barbateskovic M; Jørgensen CK; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
Syst Rev; 2021 May; 10(1):154. PubMed ID: 34034811
[TBL] [Abstract][Full Text] [Related]
12. Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis.
Tran BX; Ha GH; Vu GT; Nguyen LH; Latkin CA; Nathan K; McIntyre RS; Ho CS; Tam WW; Ho RC
Int J Environ Res Public Health; 2019 Jun; 16(13):. PubMed ID: 31247926
[TBL] [Abstract][Full Text] [Related]
13. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.
Gartlehner G; Gaynes BN; Hansen RA; Thieda P; DeVeaugh-Geiss A; Krebs EE; Moore CG; Morgan L; Lohr KN
Ann Intern Med; 2008 Nov; 149(10):734-50. PubMed ID: 19017592
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of escitalopram and severity of depression: new data].
Spadone C
Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
[TBL] [Abstract][Full Text] [Related]
15. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
[TBL] [Abstract][Full Text] [Related]
16. Drugs for Depression.
Med Lett Drugs Ther; 2020 Feb; 62(1592):25-32. PubMed ID: 32320387
[No Abstract] [Full Text] [Related]
17. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Geddes JR; Higgins JP; Churchill R; Watanabe N; Nakagawa A; Omori IM; McGuire H; Tansella M; Barbui C
Lancet; 2009 Feb; 373(9665):746-58. PubMed ID: 19185342
[TBL] [Abstract][Full Text] [Related]
19. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.
Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G
Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
